- Insider Monkey•18 hours agoBiotech Week In Review: Valeant, Progenics, Relistor and Vesneo – Valeant Pharmaceuticals Intl Inc (VRX) Progenics Pharmaceuticals, Inc. (PGNX)
Last week, the FDA had two major decisions to make regarding troubled drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The first was whether or not to approve Relistor, a combined effort between Valeant and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). The second, the same decision for Vesneo, a glaucoma drug that Valeant has developed by way of […]
- MarketWatch•4 days ago
Progenics Pharmaceuticals Inc. said Tuesday it received a $50 million milestone payment after its opioid-induced constipation drug Relistor was approved last week. The payment was from Valeant Pharmaceuticals ...
Progenics Pharmaceuticals, Inc.NasdaqGS
After hours: 5.850.00 (0.00%) as of 6:11 PM EDT
|Bid||5.60 x 5700|
|Ask||5.94 x 200|
|52wk Range||3.61 - 8.90|
|Day's Range||5.79 - 5.94|
|Avg Vol (3m)||1,374,963|
As of 4:00 PM EDT. Market closed.